Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Strangfeld

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Arthritis Care & Research|August 29, 2023
Impact of Risk Factors on COVID-19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID-19 Global Rheumatology Alliance RegistryJinoos Yazdany, Anna Ware, Zachary S Wallace, et al.
Annals of the Rheumatic Diseases|November 10, 2022
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 updateJosef S Smolen, Robert B M Landewé, Sytske Anne Bergstra, et al.
Annals of the Rheumatic Diseases|February 14, 2023
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registriesPedro M Machado, Martin Schäfer, Satveer K Mahil, et al.
Rheumatology (Oxford, England)|September 20, 2022
Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination statusSinead Maguire, Samar Al-Emadi, Paula Alba, et al.
ACR Open Rheumatology|July 23, 2022
Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance RegistryZara Izadi, Milena A Gianfrancesco, Alfredo Aguirre, et al.
Annals of the Rheumatic Diseases|February 17, 2022
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology AllianceManuel Francisco Ugarte-Gil, Graciela S Alarcón, Zara Izadi, et al.
The Lancet. Rheumatology|August 1, 2022
Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational studyZara Izadi, Milena A Gianfrancesco, Gabriela Schmajuk, et al.
The Lancet. Rheumatology|November 15, 2021
Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort studySebastian E Sattui, Richard Conway, Michael S Putman, et al.
JAMA Network Open|October 18, 2021
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19Zara Izadi, Erica J Brenner, Satveer K Mahil, et al.
Annals of the Rheumatic Diseases|May 29, 2021
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registryJeffrey A Sparks, Zachary S Wallace, Andrea M Seet, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Arthritis Care & Research|August 29, 2023
Impact of Risk Factors on COVID-19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID-19 Global Rheumatology Alliance RegistryJinoos Yazdany, Anna Ware, Zachary S Wallace, et al.
Annals of the Rheumatic Diseases|November 10, 2022
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 updateJosef S Smolen, Robert B M Landewé, Sytske Anne Bergstra, et al.
Annals of the Rheumatic Diseases|February 14, 2023
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registriesPedro M Machado, Martin Schäfer, Satveer K Mahil, et al.
Rheumatology (Oxford, England)|September 20, 2022
Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination statusSinead Maguire, Samar Al-Emadi, Paula Alba, et al.
ACR Open Rheumatology|July 23, 2022
Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance RegistryZara Izadi, Milena A Gianfrancesco, Alfredo Aguirre, et al.
Annals of the Rheumatic Diseases|February 17, 2022
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology AllianceManuel Francisco Ugarte-Gil, Graciela S Alarcón, Zara Izadi, et al.
The Lancet. Rheumatology|August 1, 2022
Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational studyZara Izadi, Milena A Gianfrancesco, Gabriela Schmajuk, et al.
The Lancet. Rheumatology|November 15, 2021
Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort studySebastian E Sattui, Richard Conway, Michael S Putman, et al.
JAMA Network Open|October 18, 2021
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19Zara Izadi, Erica J Brenner, Satveer K Mahil, et al.
Annals of the Rheumatic Diseases|May 29, 2021
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registryJeffrey A Sparks, Zachary S Wallace, Andrea M Seet, et al.
Pageof 14